Ronaldo observes scientists working on personalized nutrition in a modern lab.
Herbalife has agreed to acquire assets from Bioniq, a British personalized nutritional supplement company, to broaden its data-based wellness solutions globally. The acquisition, expected to finalize in Q2 2026, integrates Bioniq’s health-data platform with Herbalife’s manufacturing and distribution network.
The deal will see Bioniq’s personalized supplement programs, which utilize questionnaires, blood tests, and biomarker data, launched in Europe and the US later this year, with further market expansion planned. Bioniq, established in 2019, counts Cristiano Ronaldo, athlete and investor, among its shareholders and users.
Stephan Gratziani, Herbalife Worldwide CEO, highlighted the strategic importance of this acquisition for delivering personalized nutrition at scale. Vadim Fedotov, Bioniq’s founder, emphasized the goal of helping individuals manage their well-being through tailored nutrition. Ronaldo endorsed the integration of Bioniq’s tools into Herbalife’s platform.
Herbalife Israel CEO Ron Porat noted the deal’s relevance to the growing personalized nutrition trend in Israel, where supplement use is high. This move aligns with Herbalife’s broader strategy to enhance personalized health tools, building on previous collaborations to combine biometric data with customized nutrition.
The Bioniq deal remains subject to regulatory approval and is expected to close in the second quarter of 2026.
About the Author
